Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases
Background. Inflammatory bowel disease (IBD) is a serious medical and social problem, which leads to a significant interest in the study of etiology, pathogenesis, development of diagnostic and therapeutic complexes. There is growing evidence that interleukin (IL) 17 and IL-23 are potent mediators o...
Saved in:
| Main Authors: | Yu.M. Stepanov, M.V. Stoikevych, O.M. Tatarchuk, T.S. Tarasova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2025-03-01
|
| Series: | Gastroenterologìa |
| Subjects: | |
| Online Access: | https://gastro.zaslavsky.com.ua/index.php/journal/article/view/662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin biomarkers as predictive tools for lupus nephritis grade and disease activity in systemic lupus erythematosus
by: Dalia S. Saif, et al.
Published: (2025-04-01) -
Comparative Role of Anti-TNF Agents versus IL-12/23 Inhibitors in Inflammatory Bowel Disease: An Updated Review
by: Xue Bin Leong, et al.
Published: (2024-12-01) -
IL-17A, IL-17F and IL-23 in patients with rheumatoid arthritis
by: Natalia A. Lapkina, et al.
Published: (2024-09-01) -
Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01) -
Cytokine dynamics in vitiligo: the roles of interleukin-10 and interleukin-17
by: Hanan Mohammed Saied
Published: (2025-08-01)